The DOI matches its Crossref record; 214 of the 214 references it cites were found in a registry or an index.
NFκB signaling in carcinogenesis and as a potential molecular target for cancer therapy
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
3 retracted
Banerjee, S., Zhang, Y., Wang, Z. P., Che, M., Chiao, P. J., Abbruzzese, J. L., & Sarkar, F. H. (2006) · International Journal of Cancer · doi:10.1002/ijc.22332 · Cited by 93
RetractedAli, S. S., Banerjee, S., Ahmad, A., El‐Rayes, B. F., Philip, P. A., & Sarkar, F. H. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0354 · Cited by 81
RetractedBaritaki, S., Suzuki, E., Umezawa, K., Spandidos, D. A., Berenson, J. R., Daniels‐Wells, T. R., Penichet, M. L., Jazirehi, A. R., Palladino, M. A., & Bonavida, B. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.9.6199 · Cited by 78
RetractedMantovani, A., Allavena, P., Sica, A., & Balkwill, F. (2008) · Nature · doi:10.1038/nature07205 · Cited by 11,399
Autophagy in the Pathogenesis of Disease
Levine, B., & Kroemer, G. (2008) · Cell · doi:10.1016/j.cell.2007.12.018 · Cited by 7,069
Phosphorylation meets ubiquitination: the control of NF-κB activity
Karin, M., & Ben-Neriah, Y. (2000) · Annual Review of Immunology · doi:10.1146/annurev.immunol.18.1.621 · Cited by 4,766
Shared Principles in NF-κB Signaling
Hayden, M. S., & Ghosh, S. (2008) · Cell · doi:10.1016/j.cell.2008.01.020 · Cited by 4,494
Autophagy: process and function
Mizushima, N. (2007) · Genes & Development · doi:10.1101/gad.1599207 · Cited by 3,967
Missing Pieces in the NF-κB Puzzle
Ghosh, S., & Karin, M. (2002) · Cell · doi:10.1016/s0092-8674(02)00703-1 · Cited by 3,638
Autophagy as a Regulated Pathway of Cellular Degradation
Klionsky, D. J., & Emr, S. D. (2000) · Science · doi:10.1126/science.290.5497.1717 · Cited by 3,608
NF-κB: linking inflammation and immunity to cancer development and progression
Karin, M., & Greten, F. R. (2005) · Nature Reviews Immunology · doi:10.1038/nri1703 · Cited by 3,085
Defining the role of mTOR in cancer
Guertin, D. A., & Sabatini, D. M. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.05.008 · Cited by 2,833
Primary liver cancer: Worldwide incidence and trends
Bosch, F. X., Ribes, J., Díaz, M., & Cléries, R. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.09.011 · Cited by 2,477
IKKβ Links Inflammation and Tumorigenesis in a Mouse Model of Colitis-Associated Cancer
Greten, F. R., Eckmann, L., Greten, T. F., Park, J. M., Li, Z.-W., Egan, L. J., Kagnoff, M. F., & Karin, M. (2004) · Cell · doi:10.1016/j.cell.2004.07.013 · Cited by 2,433
NF-κB functions as a tumour promoter in inflammation-associated cancer
Pikarsky, E., Porat, R. M., Stein, I., Abramovitch, R., Amit, S., Kasem, S., Gutkovich-Pyest, E., Urieli-Shoval, S., Galun, E., & Ben-Neriah, Y. (2004) · Nature · doi:10.1038/nature02924 · Cited by 2,430
Integrating cell-signalling pathways with NF-κB and IKK function
Perkins, N. D. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2083 · Cited by 2,350
Autophagy promotes tumor cell survival and restricts necrosis, inflammation, and tumorigenesis
Degenhardt, K., Mathew, R., Beaudoin, B., Bray, K., Anderson, D., Chen, G., Mukherjee, C., Shi, Y., Gélinas, C., Fan, Y., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.06.001 · Cited by 2,011
NF-κB activation by tumour necrosis factor requires the Akt serine–threonine kinase
Nidai Ozes, O., Mayo, L. D., Gustin, J. A., Pfeffer, S. R., Pfeffer, L. M., & Donner, D. B. (1999) · Nature · doi:10.1038/43466 · Cited by 1,832
Molecular requirements for epithelial–mesenchymal transition during tumor progression
Huber, M. A., Kraut, N., & Beug, H. (2005) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2005.08.001 · Cited by 1,821
The epidemiology of UV induced skin cancer
Armstrong, B. K., & Kricker, A. (2001) · Journal of Photochemistry and Photobiology B: Biology · doi:10.1016/s1011-1344(01)00198-1 · Cited by 1,811
Mathew, R., Karantza-Wadsworth, V., & White, E. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2254 · Cited by 1,798
Kamata, H., Honda, S.-I., Maeda, S., Chang, L., Hirata, H., & Karin, M. (2005) · Cell · doi:10.1016/j.cell.2004.12.041 · Cited by 1,792
Therapeutic potential of inhibition of the NF-κB pathway in the treatment of inflammation and cancer
Yamamoto, Y., & Gaynor, R. B. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11914 · Cited by 1,585
Aggarwal, B. B. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.09.003 · Cited by 1,574
Control of oncogenesis and cancer therapy resistance by the transcription factor NF-κB
Baldwin, A. S. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11991 · Cited by 1,434
mTOR and cancer: insights into a complex relationship
Sabatini, D. M. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1974 · Cited by 1,322
Maeda, S., Kamata, H., Luo, J.-L., Leffert, H., & Karin, M. (2005) · Cell · doi:10.1016/j.cell.2005.04.014 · Cited by 1,164
Epithelial NEMO links innate immunity to chronic intestinal inflammation
Nenci, A., Becker, C., Wullaert, A., Gareus, R., van Loo, G., Danese, S., Huth, M., Nikolaev, A., Neufert, C., Madison, B., et al. (2007) · Nature · doi:10.1038/nature05698 · Cited by 1,077
IAP Antagonists Target cIAP1 to Induce TNFα-Dependent Apoptosis
Vince, J. E., Wong, W. W.-L., Khan, N., Feltham, R., Chau, D., Ahmed, A. U., Benetatos, C. A., Chunduru, S. K., Condon, S. M., McKinlay, M., et al. (2007) · Cell · doi:10.1016/j.cell.2007.10.037 · Cited by 1,053
Self-citationHuber, M. A., Azoitei, N., Baumann, B., Grünert, S., Sommer, A., Pehamberger, H., Kraut, N., Beug, H., & Wirth, T. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200421358 · Cited by 1,033
The IκB kinase (IKK) and NF-κB: key elements of proinflammatory signalling
Karin, M., & Delhase, M. (2000) · Seminars in Immunology · doi:10.1006/smim.2000.0210 · Cited by 955
IKK/NF- B signaling: balancing life and death - a new approach to cancer therapy
Luo, J.-L. (2005) · Journal of Clinical Investigation · doi:10.1172/jci26322 · Cited by 878
More than one way to die: apoptosis, necrosis and reactive oxygen damage
Fiers, W., Beyaert, R., Declercq, W., & Vandenabeele, P. (1999) · Oncogene · doi:10.1038/sj.onc.1203249 · Cited by 864
Abnormal Morphogenesis But Intact IKK Activation in Mice Lacking the IKKα Subunit of IκB Kinase
Hu, Y., Baud, V., Delhase, M., Zhang, P., Deerinck, T., Ellisman, M., Johnson, R., & Karin, M. (1999) · Science · doi:10.1126/science.284.5412.316 · Cited by 823
Madrid, L. V., Mayo, M. W., Reuther, J. Y., & Baldwin, A. S. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m101103200 · Cited by 777
Levine, B. (2007) · Nature · doi:10.1038/446745a · Cited by 741
Induction of gadd45β by NF-κB downregulates pro-apoptotic JNK signalling
De Smaele, E., Zazzeroni, F., Papa, S., Nguyen, D. U., Jin, R., Jones, J., Cong, R., & Franzoso, G. (2001) · Nature · doi:10.1038/35104560 · Cited by 732
Nuclear factor-κB inhibitors as sensitizers to anticancer drugs
Nakanishi, C., & Toi, M. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1588 · Cited by 724
Inhibition of JNK activation through NF-κB target genes
Tang, G., Minemoto, Y., Dibling, B., Purcell, N. H., Li, Z., Karin, M., & Lin, A. (2001) · Nature · doi:10.1038/35104568 · Cited by 721
TNF-α in Cancer Treatment: Molecular Insights, Antitumor Effects, and Clinical Utility
van Horssen, R., ten Hagen, T. L. M., & Eggermont, A. M. M. (2006) · The Oncologist · doi:10.1634/theoncologist.11-4-397 · Cited by 701
Nuclear factor-κB and inhibitor of κB kinase pathways in oncogenic initiation and progression
Bassères, D. S., & Baldwin, A. S. (2006) · Oncogene · doi:10.1038/sj.onc.1209942 · Cited by 667
Pham, C. G., Bubici, C., Zazzeroni, F., Papa, S., Jones, J., Alvarez, K., Jayawardena, S., De Smaele, E., Cong, R., Beaumont, C., et al. (2004) · Cell · doi:10.1016/j.cell.2004.10.017 · Cited by 663
Helbig, G., Christopherson, K. W., Bhat-Nakshatri, P., Kumar, S., Kishimoto, H., Miller, K. D., Broxmeyer, H. E., & Nakshatri, H. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300609200 · Cited by 639
IKKβ Suppression of TSC1 Links Inflammation and Tumor Angiogenesis via the mTOR Pathway
Lee, D.-F., Kuo, H.-P., Chen, C.-T., Hsu, J.-M., Chou, C.-K., Wei, Y., Sun, H.-L., Li, L.-Y., Ping, B., Huang, W.-C., et al. (2007) · Cell · doi:10.1016/j.cell.2007.05.058 · Cited by 637
NF-κB and cancer — identifying targets and mechanisms
Naugler, W. E., & Karin, M. (2008) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2008.01.020 · Cited by 636
Akt-dependent regulation of NF-κB is controlled by mTOR and Raptor in association with IKK
Dan, H. C., Cooper, M. J., Cogswell, P. C., Duncan, J. A., Ting, J. P.-Y., & Baldwin, A. S. (2008) · Genes & Development · doi:10.1101/gad.1662308 · Cited by 636
Shen, H.-M., & Liu, Z.-G. (2006) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2005.10.056 · Cited by 629
Self-citationBhaumik, D., Scott, G. K., Schokrpur, S., Patil, C. K., Campisi, J., & Benz, C. C. (2008) · Oncogene · doi:10.1038/onc.2008.171 · Cited by 622
Limb and Skin Abnormalities in Mice Lacking IKKα
Takeda, K., Takeuchi, O., Tsujimura, T., Itami, S., Adachi, O., Kawai, T., Sanjo, H., Yoshikawa, K., Terada, N., & Akira, S. (1999) · Science · doi:10.1126/science.284.5412.313 · Cited by 609
Transcriptional Cross Talk between NF-κB and p53
Webster, G. A., & Perkins, N. D. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.5.3485 · Cited by 598
Deletion of NEMO/IKKγ in Liver Parenchymal Cells Causes Steatohepatitis and Hepatocellular Carcinoma
Luedde, T., Beraza, N., Kotsikoris, V., van Loo, G., Nenci, A., De Vos, R., Roskams, T., Trautwein, C., & Pasparakis, M. (2007) · Cancer Cell · doi:10.1016/j.ccr.2006.12.016 · Cited by 597
Aggarwal, B. B., Shishodia, S., Takada, Y., Banerjee, S., Newman, R. A., Bueso-Ramos, C. E., & Price, J. E. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1192 · Cited by 584
Autocrine TNFα Signaling Renders Human Cancer Cells Susceptible to Smac-Mimetic-Induced Apoptosis
Petersen, S. L., Wang, L., Yalcin-Chin, A., Li, L., Peyton, M., Minna, J., Harran, P., & Wang, X. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.08.029 · Cited by 571
Anti‐cancer properties of anthraquinones from rhubarb
Huang, Q., Lu, G., Shen, H., Chung, M. C. M., & Ong, C. N. (2007) · Medicinal Research Reviews · doi:10.1002/med.20094 · Cited by 559
Self-citationHuang, S., Pettaway, C. A., Uehara, H., Bucana, C. D., & Fidler, I. J. (2001) · Oncogene · doi:10.1038/sj.onc.1204535 · Cited by 556
Houston, M. A., Abendroth, K., Baldwin, A. S., & Liu, R. (2001) · PubMed · doi:10.17615/k359-fr77 · Cited by 547
Autophagy: Basic Principles and Relevance to Disease
Kundu, M., & Thompson, C. B. (2008) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev.pathmechdis.2.010506.091842 · Cited by 523
Sakon, S., Xue, X., Takekawa, M., Sasazuki, T., Okazaki, T., Kojima, Y., Piao, J., Yagita, H., Okumura, K., Doi, T., et al. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg379 · Cited by 497
Sakurai, T., He, G., Matsuzawa, A., Yu, G.-Y., Maeda, S., Hardiman, G., & Karin, M. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.06.016 · Cited by 487
TNF-mediated inflammatory skin disease in mice with epidermis-specific deletion of IKK2
Pasparakis, M., Courtois, G., Hafner, M., Schmidt-Supprian, M., Nenci, A., Toksoy, A., Krampert, M., Goebeler, M., Gillitzer, R., Israel, A., et al. (2002) · Nature · doi:10.1038/nature00820 · Cited by 470
IKK1-deficient mice exhibit abnormal development of skin and skeleton
Li, Q., Lu, Q., Hwang, J. Y., Buscher, D., Lee, K.-F., Izpisua-Belmonte, J. C., & Verma, I. M. (1999) · Genes & Development · doi:10.1101/gad.13.10.1322 · Cited by 469
TRAIL signalling: Decisions between life and death
Falschlehner, C., Emmerich, C. H., Gerlach, B., & Walczak, H. (2007) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2007.02.007 · Cited by 458
Multiple Viral Strategies of HTLV-1 for Dysregulation of Cell Growth Control
Yoshida, M. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.475 · Cited by 456
Srinivasula, S. M., & Ashwell, J. D. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.03.008 · Cited by 450
Gozuacik, D., & Kimchi, A. (2007) · Current Topics in Developmental Biology · doi:10.1016/s0070-2153(06)78006-1 · Cited by 437
Nuclear cytokine-activated IKKα controls prostate cancer metastasis by repressing Maspin
Luo, J.-L., Tan, W., Ricono, J. M., Korchynskyi, O., Zhang, M., Gonias, S. L., Cheresh, D. A., & Karin, M. (2007) · Nature · doi:10.1038/nature05656 · Cited by 436
Ionizing radiation and short wavelength UV activate NF-κB through two distinct mechanisms
Li, N., & Karin, M. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.22.13012 · Cited by 427
Nuclear Factor-κB Activation: From Bench to Bedside
Sethi, G., Sung, B., & Aggarwal, B. B. (2008) · Experimental Biology and Medicine · doi:10.3181/0707-mr-196 · Cited by 417
Lin, Y., Choksi, S., Shen, H.-M., Yang, Q.-F., Hur, G. M., Kim, Y. S., Tran, J. H., Nedospasov, S. A., & Liu, Z.-G. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m313141200 · Cited by 412
Self-citationNF-κB Activation Represses Tumor Necrosis Factor-α-induced Autophagy
Djavaheri-Mergny, M., Amelotti, M., Mathieu, J., Besançon, F., Bauvy, C., Souquère, S., Pierron, G., & Codogno, P. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m602097200 · Cited by 407
A Fourth IκB Protein within the NF-κB Signaling Module
Basak, S., Kim, H., Kearns, J. D., Tergaonkar, V., O'Dea, E., Werner, S. L., Benedict, C. A., Ware, C. F., Ghosh, G., Verma, I. M., et al. (2007) · Cell · doi:10.1016/j.cell.2006.12.033 · Cited by 404
Self-citationBubici, C., Papa, S., Dean, K., & Franzoso, G. (2006) · Oncogene · doi:10.1038/sj.onc.1209936 · Cited by 399
Bhardwaj, A., Sethi, G., Vadhan-Raj, Bueso-Ramos, C., Takada, Y., Gaur, U., Nair, A. S., Shishodia, S., & Aggarwal, B. B. (2007) · Blood · doi:10.1182/blood-2006-02-003988 · Cited by 395
NF-κB and cell-cycle regulation: the cyclin connection
JOYCE, D., ALBANESE, C., STEER, J., FU, M., BOUZAHZAH, B., & PESTELL, R. (2001) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(00)00018-6 · Cited by 393
NF-κB and IKK as therapeutic targets in cancer
Kim, H. J., Hawke, N., & Baldwin, A. S. (2006) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401877 · Cited by 391
Sizemore, N., Lerner, N., Dombrowski, N., Sakurai, H., & Stark, G. R. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m110572200 · Cited by 390
Anti-Cancer Potential of Sesquiterpene Lactones: Bioactivity and Molecular Mechanisms
Zhang, S., Won, Y.-K., Ong, C.-N., & Shen, H.-M. (2005) · Current Medicinal Chemistry-Anti-Cancer Agents · doi:10.2174/1568011053765976 · Cited by 383
Self-citationCellular and molecular events leading to the development of skin cancer
Melnikova, V. O., & Ananthaswamy, H. N. (2005) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/j.mrfmmm.2004.11.015 · Cited by 376
Li, Y., Ahmed, F., Ali, S., Philip, P. A., Kucuk, O., & Sarkar, F. H. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4604 · Cited by 376
Caspase-independent cell death in T lymphocytes
Jäättelä, M., & Tschopp, J. (2003) · Nature Immunology · doi:10.1038/ni0503-416 · Cited by 367
Reactive oxygen species mediate crosstalk between NF-κB and JNK
Nakano, H., Nakajima, A., Sakon-Komazawa, S., Piao, J.-H., Xue, X., & Okumura, K. (2006) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401830 · Cited by 366
Indole-3-carbinol as a chemopreventive and anti-cancer agent
Weng, J.-R., Tsai, C.-H., Kulp, S. K., & Chen, C.-S. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.01.033 · Cited by 327
van Hogerlinden, M., Rozell, B., Ährlund‐Richter, L., & Toftgård, R. (1999) · PubMed · Cited by 319
Enhancement of radiosensitivity by proteasome inhibition: Implications for a role of NF-κB
Russo, S. M., Tepper, J. E., Baldwin, A. S., Liu, R., Adams, J., Elliott, P., & Cusack, J. C. (2001) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(01)01446-8 · Cited by 318
CK2 Is a C-Terminal IκB Kinase Responsible for NF-κB Activation during the UV Response
Kato, T., Delhase, M., Hoffmann, A., & Karin, M. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00358-7 · Cited by 314
p53 stabilization is decreased upon NFκB activation
Tergaonkar, V., Pando, M., Vafa, O., Wahl, G., & Verma, I. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00068-5 · Cited by 313
Self-citationVentura, J.-J., Cogswell, P., Flavell, R. A., Baldwin, A. S., & Davis, R. J. (2004) · Genes & Development · doi:10.1101/gad.1223004 · Cited by 303
Beyaert, R., Heyninck, K., & Van Huffel, S. (2000) · Biochemical Pharmacology · doi:10.1016/s0006-2952(00)00404-4 · Cited by 301
Patel, N. M., Nozaki, S., Shortle, N. H., Bhat-Nakshatri, P., Newton, T. R., Rice, S., Gelfanov, V., Boswell, S. H., Goulet, R. J., Sledge, G. W., et al. (2000) · Oncogene · doi:10.1038/sj.onc.1203768 · Cited by 294
Xiao, G. (2001) · The EMBO Journal · doi:10.1093/emboj/20.23.6805 · Cited by 294
Nuclear Factor-κB in Development, Prevention, and Therapy of Cancer
Van Waes, C. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2221 · Cited by 292
TNF receptor superfamily‐induced cell death: redox‐dependent execution
Shen, H.-M., & Pervaiz, S. (2006) · The FASEB Journal · doi:10.1096/fj.05-5603rev · Cited by 288
Self-citationInflammation-associated cancer: NF-κB is the lynchpin
Li, Q., Withoff, S., & Verma, I. M. (2005) · Trends in Immunology · doi:10.1016/j.it.2005.04.003 · Cited by 268
NF‐κB as a potential molecular target for cancer therapy
Lee, C. H., Jeon, Y., Kim, S., & Song, Y. (2007) · BioFactors · doi:10.1002/biof.5520290103 · Cited by 248
Dai, Y., Rahmani, M., Dent, P., & Grant, S. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.13.5429-5444.2005 · Cited by 245
NFκB pathway: A good signaling paradigm and therapeutic target
Tergaonkar, V. (2006) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2006.03.023 · Cited by 235
Self-citationPapa, S., Bubici, C., Zazzeroni, F., Pham, C. G., Kuntzen, C., Knabb, J. R., Dean, K., & Franzoso, G. (2006) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401865 · Cited by 235
Activation of NF-κB by HTLV-I and implications for cell transformation
Sun, S.-C., & Yamaoka, S. (2005) · Oncogene · doi:10.1038/sj.onc.1208969 · Cited by 231
Bava, S. V., Puliappadamba, V. T., Deepti, A., Nair, A., Karunagaran, D., & Anto, R. J. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m410647200 · Cited by 229
Sayers, T. J., Brooks, A. D., Koh, C. Y., Ma, W., Seki, N., Raziuddin, A., Blazar, B. R., Zhang, X., Elliott, P. J., & Murphy, W. J. (2003) · Blood · doi:10.1182/blood-2002-09-2975 · Cited by 227
NF-κB-mediated adaptive resistance to ionizing radiation
Mokim Ahmed, K., & Li, J. J. (2008) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2007.09.022 · Cited by 226
Sequential DNA damage-independent and -dependent activation of NF-kappa B by UV
Bender, K. (1998) · The EMBO Journal · doi:10.1093/emboj/17.17.5170 · Cited by 223
Kunnumakkara, A. B., Diagaradjane, P., Guha, S., Deorukhkar, A., Shentu, S., Aggarwal, B. B., & Krishnan, S. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-4722 · Cited by 217
Robek, M. D., & Ratner, L. (1999) · Journal of Virology · doi:10.1128/jvi.73.6.4856-4865.1999 · Cited by 212
Inhibition of NFκB Increases the Efficacy of Cisplatin in in Vitro and in Vivo Ovarian Cancer Models
Mabuchi, S., Ohmichi, M., Nishio, Y., Hayasaka, T., Kimura, A., Ohta, T., Saito, M., Kawagoe, J., Takahashi, K., Yada-Hashimoto, N., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m313709200 · Cited by 211
Denecker, G., Vercammen, D., Steemans, M., Vanden Berghe, T., Brouckaert, G., Van Loo, G., Zhivotovsky, B., Fiers, W., Grooten, J., Declercq, W., et al. (2001) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4400883 · Cited by 205
Cooper, S., & Bowden, G. (2007) · Current Cancer Drug Targets · doi:10.2174/156800907780809714 · Cited by 204
Raffoul, J. J., Wang, Y., Kucuk, O., Forman, J. D., Sarkar, F. H., & Hillman, G. G. (2006) · BMC Cancer · doi:10.1186/1471-2407-6-107 · Cited by 203
Complexity of the TOR signaling network
Inoki, K., & Guan, K.-L. (2006) · Trends in Cell Biology · doi:10.1016/j.tcb.2006.02.002 · Cited by 194
Sun, S.-C., & Ballard, D. W. (1999) · Oncogene · doi:10.1038/sj.onc.1203220 · Cited by 185
Jeong, S.-J., Pise-Masison, C. A., Radonovich, M. F., Park, H. U., & Brady, J. N. (2005) · Oncogene · doi:10.1038/sj.onc.1208825 · Cited by 185
Positive and negative signaling components involved in TNFα-induced NF-κB activation
Li, H., & Lin, X. (2008) · Cytokine · doi:10.1016/j.cyto.2007.09.016 · Cited by 175
Dissection of the NF-κB signalling cascade in transgenic and knockout mice
Pasparakis, M., Luedde, T., & Schmidt-Supprian, M. (2006) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401870 · Cited by 172
Ganten, T. M., Koschny, R., Haas, T. L., Sykora, J., Li-Weber, M., Herzer, K., & Walczak, H. (2005) · Hepatology · doi:10.1002/hep.20807 · Cited by 170
Double-edged swords as cancer therapeutics: simultaneously targeting p53 and NF-κB pathways
Dey, A., Tergaonkar, V., & Lane, D. P. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2759 · Cited by 169
Self-citationJavvadi, P., Segan, A. T., Tuttle, S. W., & Koumenis, C. (2008) · Molecular Pharmacology · doi:10.1124/mol.107.043554 · Cited by 166
Zhang, D., & Armstrong, J. S. (2007) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4402072 · Cited by 165
Opposing functions of IKKβ during acute and chronic intestinal inflammation
Eckmann, L., Nebelsiek, T., Fingerle, A. A., Dann, S. M., Mages, J., Lang, R., Robine, S., Kagnoff, M. F., Schmid, R. M., Karin, M., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0808216105 · Cited by 165
Shankar, S., Ganapathy, S., Chen, Q., & Srivastava, R. K. (2008) · Molecular Cancer · doi:10.1186/1476-4598-7-16 · Cited by 165
Tergaonkar, V., Bottero, V., Ikawa, M., Li, Q., & Verma, I. M. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.22.8070-8083.2003 · Cited by 161
Self-citationKamat, A. M., Sethi, G., & Aggarwal, B. B. (2007) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0545 · Cited by 160
Nakshatri, H., Rice, S. E., & Bhat‐Nakshatri, P. (2004) · Oncogene · doi:10.1038/sj.onc.1207995 · Cited by 159
Sweeney, C. J., Mehrotra, S., Sadaria, M. R., Kumar, S., Shortle, N. H., Roman, Y., Sheridan, C., Campbell, R. A., Murry, D. J., Badve, S., et al. (2005) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0030 · Cited by 158
Essential Roles of Receptor-Interacting Protein and TRAF2 in Oxidative Stress-Induced Cell Death
Shen, H., Lin, Y., Choksi, S., Tran, J. H., Jin, T., Chang, L., Karin, M., Zhang, J., & Liu, Z.-G. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.13.5914-5922.2004 · Cited by 154
Self-citationRegulation of p53 tumour suppressor target gene expression by the p52 NF‐κB subunit
Schumm, K., Rocha, S., Caamaño, J., & Perkins, N. D. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601343 · Cited by 153
Distinct roles of IκB proteins in regulating constitutive NF-κB activity
Tergaonkar, V., Correa, R. G., Ikawa, M., & Verma, I. M. (2005) · Nature Cell Biology · doi:10.1038/ncb1296 · Cited by 152
Self-citationCritical role for NF‐κB‐induced JunB in VEGF regulation and tumor angiogenesis
Schmidt, D., Textor, B., Pein, O. T., Licht, A. H., Andrecht, S., Sator‐Schmitt, M., Fusenig, N. E., Angel, P. E., & Schorpp‐Kistner, M. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601539 · Cited by 151
Satou, Y., Nosaka, K., Koya, Y., Yasunaga, J., Toyokuni, S., & Matsuoka, M. (2004) · Leukemia · doi:10.1038/sj.leu.2403400 · Cited by 148
Ju, W., Wang, X., Shi, H., Chen, W., Belinsky, S. A., & Lin, Y. (2007) · Molecular Pharmacology · doi:10.1124/mol.106.032185 · Cited by 147
Tumor suppression by autophagy through the management of metabolic stress
Jin, S. V., & White, E. (2008) · Autophagy · doi:10.4161/auto.5830 · Cited by 146
Signaling Pathways Responsible for Cancer Cell Invasion as Targets for Cancer Therapy
Slíva, D. (2004) · Current Cancer Drug Targets · doi:10.2174/1568009043332961 · Cited by 144
Characterization of NF-κΒ/IκΒ Proteins in Zebra Fish and Their Involvement in Notochord Development
Correa, R. G., Tergaonkar, V., Ng, J. K., Dubova, I., Izpisúa‐Belmonte, J. C., & Verma, I. M. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.12.5257-5268.2004 · Cited by 142
Self-citationQing, G., Yan, P., & Xiao, G. (2006) · Cell Research · doi:10.1038/sj.cr.7310109 · Cited by 140
NF-κB regulation of endothelial cell function during LPS-induced toxemia and cancer
Kisseleva, T., Li, S., Vorontchikhina, M., Feirt, N. M., Kitajewski, J., & Schindler, C. (2006) · Journal of Clinical Investigation · doi:10.1172/jci27392 · Cited by 140
TRAIL: a multifunctional cytokine
Schaefer, U., Voloshanenko, O., Willen, D., & Walczak, H. (2007) · Frontiers in bioscience · doi:10.2741/2354 · Cited by 138
Kinase regulation in inflammatory response
Delhase, M., Li, N., & Karin, M. (2000) · Nature · doi:10.1038/35019154 · Cited by 133
IKKα Is Required to Maintain Skin Homeostasis and Prevent Skin Cancer
Liu, B., Xia, X., Zhu, F., Park, E., Carbajal, S., Kiguchi, K., DiGiovanni, J., Fischer, S. M., & Hu, Y. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.07.017 · Cited by 133
Nuclear factor-κB maintains TRAIL resistance in human pancreatic cancer cells
Khanbolooki, S., Nawrocki, S. T., Arumugam, T., Andtbacka, R. H. I., Pino, M. S., Kurzrock, R., Logsdon, C. D., Abbruzzese, J. L., & McConkey, D. J. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0075 · Cited by 132
Can NF-κB be a target for novel and efficient anti-cancer agents?
Olivier, S., Robe, P. A. J. T., & Bours, V. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.07.023 · Cited by 129
Essential role of tuberous sclerosis genes TSC1 and TSC2 in NF-κB activation and cell survival
Ghosh, S., Tergaonkar, V., Rothlin, C. V., Correa, R. G., Bottero, V., Bist, P., Verma, I. M., & Hunter, T. R. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.08.007 · Cited by 128
Self-citationNF-κB: a new player in angiostatic therapy
Tabruyn, S. P., & Griffioen, A. W. (2008) · Angiogenesis · doi:10.1007/s10456-008-9094-4 · Cited by 127
Li, Y., Ellis, K.-L., Ali, S. S., El-Rayes, B. F., Nedeljkovic-Kurepa, A., Kucuk, O., Philip, P. A., & Sarkar, F. H. (2004) · Pancreas · doi:10.1097/00006676-200405000-00020 · Cited by 126
NF-κB-dependent MnSOD expression protects adenocarcinoma cells from TNF-α-induced apoptosis
Delhalle, S., Deregowski, V., Benoît, V., Merville, M., & Bours, V. (2002) · Oncogene · doi:10.1038/sj.onc.1205489 · Cited by 125
Waes, C. V., Chang, A. A., Lebowitz, P. F., Druzgal, C. H., Chen, Z., Elsayed, Y. A., Sunwoo, J. B., Rudy, S. F., Morris, J. C., Mitchell, J. B., et al. (2005) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2005.05.007 · Cited by 123
Deeb, D., Jiang, H., Gao, X., Al‐Holou, S. N., Danyluk, A., Dulchavsky, S. A., & Gautam, S. C. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.117721 · Cited by 123
NF‐κB activity blockade impairs the angiogenic potential of human pancreatic cancer cells
Xiong, H. Q., Abbruzzese, J. L., Lin, E. H., Wang, L., Zheng, L., & Xie, K. (2003) · International Journal of Cancer · doi:10.1002/ijc.11562 · Cited by 122
NF-kappaB: a potential target for cancer chemoprevention and therapy
Fazlul, H. S. (2007) · Frontiers in bioscience · doi:10.2741/2900 · Cited by 121
Voortman, J., Resende, T. P., Hassan, M., Giaccone, G., & Kruyt, F. A. E. (2007) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-07-0167 · Cited by 120
Mabuchi, S., Ohmichi, M., Nishio, Y., Hayasaka, T., Kimura, A., Ohta, T., Kawagoe, J., Takahashi, K., Yada-Hashimoto, N., Seino-Noda, H., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0958 · Cited by 120
Anticancer Properties of Anthraquinones from Rhubarb
Huang, Q. B., Lu, G., Shen, H., Chung, M. C. M., & Ong, C. N. (2007) · ChemInform · doi:10.1002/chin.200747265 · Cited by 119
Self-citationZhang, S., Lin, Y., Kim, Y., Hande, M. P., Liu, Z., & Shen, H.-M. (2007) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4402088 · Cited by 117
Self-citationAll Roads Lead to mTOR: Integrating Inflammation and Tumor Angiogenesis
Lee, D.-F., & Hung, M.-C. (2007) · Cell Cycle · doi:10.4161/cc.6.24.5085 · Cited by 115
Lind, M. H., Rozell, B., Wallin, R. P. A., van Hogerlinden, M., Ljunggren, H., Toftgård, R., & Sur, I. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0307106101 · Cited by 115
Nutrient sensing in the mTOR/S6K1 signalling pathway
Gulati, P., & Thomas, G. (2007) · Biochemical Society Transactions · doi:10.1042/bst0350236 · Cited by 115
NF-κB Signaling and Carcinogenesis
Okamoto, T., Sanda, T., & Asamitsu, K. (2007) · Current Pharmaceutical Design · doi:10.2174/138161207780162944 · Cited by 115
Nuclear Ubiquitin Ligases, NF-κB Degradation, and the Control of Inflammation
Natoli, G., & Chiocca, S. (2008) · Science Signaling · doi:10.1126/stke.11pe1 · Cited by 114
Qing, G., Yan, P., Qu, Z., Liu, H., & Xiao, G. (2007) · Cell Research · doi:10.1038/cr.2007.47 · Cited by 113
Zhang, S. (2004) · Carcinogenesis · doi:10.1093/carcin/bgh234 · Cited by 113
Luteolin sensitizes tumor necrosis factor-α-induced apoptosis in human tumor cells
Shi, R., Ong, C. N., & Shen, H. (2004) · Oncogene · doi:10.1038/sj.onc.1208046 · Cited by 110
Self-citationDai, Y., Pei, X., Rahmani, M., Conrad, D. H., Dent, P., & Grant, S. (2003) · Blood · doi:10.1182/blood-2003-09-3037 · Cited by 107
Reece, D. E., Rodriguez, G. P., Chen, C. I., Trudel, S., Kukreti, V., Mikhael, J. R., Pantoja, M. A., Xu, W., & Stewart, A. K. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.14.2372 · Cited by 103
Resveratrol sensitizes melanomas to TRAIL through modulation of antiapoptotic gene expression
Ivanov, V. N., Partridge, M. A., Johnson, G. E., Huang, S. X. L., Zhou, H., & Hei, T. K. (2007) · Experimental Cell Research · doi:10.1016/j.yexcr.2007.12.012 · Cited by 100
IKKα, a critical regulator of epidermal differentiation and a suppressor of skin cancer
Descargues, P., Sil, A. K., & Karin, M. (2008) · The EMBO Journal · doi:10.1038/emboj.2008.196 · Cited by 99
White, E. (2008) · Autophagy · doi:10.4161/auto.5907 · Cited by 97
p53 and NF-κB Crosstalk: IKKα Tips the Balance
Tergaonkar, V., & Perkins, N. D. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.04.006 · Cited by 97
Self-citationFabre, C., Carvalho, G., Tasdemir, E., Braun, T., Adès, L., Grosjean, J., Boehrer, S., Métivier, D., Souquère, S., Pierron, G., et al. (2007) · Oncogene · doi:10.1038/sj.onc.1210187 · Cited by 96
Sun, Y., Clair, D. K. S., Fang, F., Warren, G. W., Rangnekar, V. M., Crooks, P. A., & Clair, W. H. S. (2007) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-07-0186 · Cited by 94
Bortezomib in the front-line treatment of multiple myeloma
Richardson, P. G. G., Mitsiades, C. S., Schlossman, R. L., Ghobrial, I. M., Hideshima, T., Munshi, N. C., & Anderson, K. C. (2008) · Expert Review of Anticancer Therapy · doi:10.1586/14737140.8.7.1053 · Cited by 93
Regulation of Autophagy by NF-kappaB Transcription Factor and Reactives Oxygen Species
Djavaheri‐Mergny, M., Amelotti, M., Mathieu, J., Besançon, F., Bauvy, C., & Codogno, P. (2007) · Autophagy · doi:10.4161/auto.4248 · Cited by 92
García, M. G., Alaniz, L. D., Lopes, E. C., Blanco, G. A. C., Hajos, S. E., & Álvarez, É. (2005) · Leukemia Research · doi:10.1016/j.leukres.2005.05.004 · Cited by 91
Harms‐Ringdahl, M., Nicotera, P., & Radford, I. R. (1996) · Mutation Research/Reviews in Genetic Toxicology · doi:10.1016/s0165-1110(96)90038-x · Cited by 89
Zebrafish IκB Kinase 1 Negatively Regulates NF-κB Activity
Correa, R. G., Matsui, T., Tergaonkar, V., Rodríguez-Esteban, C., Izpisúa‐Belmonte, J. C., & Verma, I. M. (2005) · Current Biology · doi:10.1016/j.cub.2005.06.023 · Cited by 88
Self-citationAravindan, N., Madhusoodhanan, R., Ahmad, S. N. S., Johnson, D. A., & Herman, T. S. (2008) · Cancer Biology & Therapy · doi:10.4161/cbt.7.4.5534 · Cited by 87
Chemopreventive activity of parthenolide against UVB-induced skin cancer and its mechanisms
Won, Y.-K., Ong, C. N., Shi, X., & Shen, H. (2004) · Carcinogenesis · doi:10.1093/carcin/bgh151 · Cited by 80
Self-citationReduction in IκB Kinase α Expression Promotes the Development of Skin Papillomas and Carcinomas
Park, E., Zhu, F., Liu, B., Xia, X., Shen, J., Bustos, T., Fischer, S. M., & Hu, Y. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0590 · Cited by 77
Ang, H., & Tergaonkar, V. (2007) · BioEssays · doi:10.1002/bies.20647 · Cited by 75
Self-citationJohnson, G. E., Ivanov, V. N., & Hei, T. K. (2008) · APOPTOSIS · doi:10.1007/s10495-008-0212-y · Cited by 74
Dey, A., Wong, E. T., Cheok, C. F., Tergaonkar, V., & Lane, D. P. (2007) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4402257 · Cited by 73
Self-citationDuan, J., Friedman, J., Nottingham, L. K., Chen, Z., Ara, G., & Waes, C. V. (2007) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0285 · Cited by 73
Tumor necrosis factor (TNF) biology and cell death
Bertazza, L., & Mocellin, S. (2007) · Frontiers in bioscience · doi:10.2741/2881 · Cited by 71
Nutlin-3 inhibits the NFκB Pathway in a p53 Dependent Manner: Implications in Lung Cancer Therapy
Dey, A., Wong, E. T., Bist, P., Tergaonkar, V., & Lane, D. (2007) · Cell Cycle · doi:10.4161/cc.6.17.4643 · Cited by 70
Self-citationPéloponèse, J., Yeung, M. L., & Jeang, K. (2006) · Immunologic Research · doi:10.1385/ir:34:1:1 · Cited by 70
Chen, J., Chou, C., Chang, Y.-F., & Chen, C. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.12.8030 · Cited by 68
Hong, J. T., Kim, E. J., Ahn, K. S., Jung, K. M., Yun, Y. P., Park, Y., & Lee, S. H. (2001) · Molecular Carcinogenesis · doi:10.1002/mc.1050 · Cited by 68
The Two-Faced NF-κB in the Skin
Sur, I., Ulvmar, M. H., & Toftgård, R. (2008) · International Reviews of Immunology · doi:10.1080/08830180802130319 · Cited by 65
The Akt inhibitor deguelin, is an angiopreventive agent also acting on the NF- B pathway
Dell’Eva, R., Ambrosini, C., Minghelli, S., Noonan, D. M., Albini, A., & Ferrari, N. (2006) · Carcinogenesis · doi:10.1093/carcin/bgl162 · Cited by 65
Liao, H., Kuo, C., Yang, Y., Lin, C.-P., Tai, H.-C., Chen, Y.-Y., & Chen, Y.-J. (2005) · Journal of Radiation Research · doi:10.1269/jrr.46.387 · Cited by 62
Shanmugam, R., Jayaprakasan, V., Gökmen‐Polar, Y., Kelich, S. L., Miller, K. D., Yip-Schneider, M., Liang Cheng, C., Bhat‐Nakshatri, P., Sledge, G. W., Nakshatri, H., et al. (2006) · The Prostate · doi:10.1002/pros.20482 · Cited by 60
A new role for NF-κB in angiogenesis inhibition
Tabruyn, S. P., & Griffioen, A. W. (2007) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4402156 · Cited by 56
Targeting Molecular Determinants of Tumor Chemo-Radioresistance
Milas, L., Raju, U., LIAO, Z., & Ajani, J. A. (2005) · Seminars in Oncology · doi:10.1053/j.seminoncol.2005.04.028 · Cited by 49
Tabruyn, S. P., Sabatel, C., Nguyen, N.-Q.-N., Verhaeghe, C., Castermans, K., Malvaux, L., Griffioen, A. W., MARTIAL, J. A., & Struman, I. (2007) · Molecular Endocrinology · doi:10.1210/me.2007-0021 · Cited by 48
Bair, W. B., Hart, N., Einspahr, J. G., Liu, G., Dong, Z., Alberts, D. S., & Bowden, G. T. (2002) · PubMed · Cited by 47
An, F., Drummond, D. C., Wilson, S. M., Kirpotin, D. B., Nishimura, S. L., Broaddus, V. C., & Liu, B. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-07-2132 · Cited by 44
Zhang, S., Shen, H., & Ong, C. N. (2005) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0249 · Cited by 42
Self-citationRalstin, M. C., Gage, E. A., Yip-Schneider, M., Klein, P. J., Wiebke, E. A., & Schmidt, C. M. (2006) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-05-0157 · Cited by 40
Antimyeloma Effects of a Sesquiterpene Lactone Parthenolide
Suvannasankha, A., Crean, C., Shanmugam, R., Farag, S. S., Abonour, R., Boswell, H. S., & Nakshatri, H. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1359 · Cited by 39
Meng, Z., Mitsutake, N., Nakashima, M., Starenki, D., Matsuse, M., Takakura, S., Namba, H., Saenko, V., Umezawa, K., Ohtsuru, A., et al. (2008) · Endocrinology · doi:10.1210/en.2008-0279 · Cited by 38
Miyazato, A., Sheleg, S. V., Iha, H., Li, Y., & Jeang, K. (2005) · Journal of Virology · doi:10.1128/jvi.79.14.9346-9350.2005 · Cited by 37
Cited by
Sever, R., & Brugge, J. S. (2015) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006098 · Cited by 989
Inflammation and cancer: interweaving microRNA, free radical, cytokine and p53 pathways
Schetter, A. J., Heegaard, N. H. H., & Harris, C. C. (2010) · Carcinogenesis · doi:10.1093/carcin/bgp272 · Cited by 657
The Multifaceted Role of Curcumin in Cancer Prevention and Treatment
Shanmugam, M., Rane, G., Kanchi, M., Arfuso, F., Chinnathambi, A., Zayed, M., Alharbi, S., Tan, B., Kumar, A., & Sethi, G. (2015) · Molecules · doi:10.3390/molecules20022728 · Cited by 510
Biological activity of piceatannol: Leaving the shadow of resveratrol
Piotrowska, H., Kucinska, M., & Murias, M. (2012) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2011.11.001 · Cited by 476
Oxidative stress and oxidative damage in chemical carcinogenesis
Klaunig, J. E., Wang, Z., Pu, X., & Zhou, S. (2011) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2009.11.028 · Cited by 470
Metadata
- Authors
- Shen, H.-M., & Tergaonkar, V.
- Venue
- Apoptosis
- Published
- 2009-02-11
- Volume
- 14
- Issue
- 4
- Pages
- 348-363
- ISSN
- 1360-8185 (ISSN-L)
- 1573-675X
- OpenAlex
- W2059132322
- Cited by
- 275
- References
- 214
- FWCI
- 10.20
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.